🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
134.00
-1.95 (-1.43%)
At close: Nov 18, 2026, 4:00 PM EST
133.76
-0.24 (-0.18%)
Pre-market: Nov 19, 2026, 8:22 AM EST

Axsome Therapeutics Revenue

Axsome Therapeutics had revenue of $259.69M in the quarter ending September 30, 2026, with 51.87% growth. This brings the company's total for the last twelve months to $865.27M, up 54.16% year-over-year. In the year 2025, Axsome Therapeutics had annual revenue of $638.50M with 65.55% growth. That makes Axsome Therapeutics the 8,334th largest company in the world by revenue and 1,892nd in the United States.

Revenue (ttm)
$865.27M
Revenue Growth
+54.16%
P/S Ratio
8.15
Revenue / Employee
$622,495
Employees
1,390
Market Cap
7.05B

Revenue Chart

Revenue by Geography

  • United States 628.62M 98.5%
  • Outside of The United States 9.88M 1.5%
Fiscal year ended Dec 31, 2025 See the full Axsome Therapeutics breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025638.50M252.80M65.55%
Dec 31, 2024385.69M115.09M42.53%
Dec 31, 2023270.60M220.56M440.80%
Dec 31, 202250.04M--
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.